213 results on '"Mikelis, Constantinos M."'
Search Results
2. Angiopoietin-2-induced lymphatic endothelial cell migration drives lymphangiogenesis via the β1 integrin-RhoA-formin axis
3. Chlorinated benzothiadiazines inhibit angiogenesis through suppression of VEGFR2 phosphorylation
4. Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders
5. Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer
6. Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle Progression.
7. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance
8. Pleiotrophin selectively binds to vascular endothelial growth factor receptor 2 and inhibits or stimulates cell migration depending on ανβ3 integrin expression
9. Murine Dermal Lymphatic Endothelial Cell Isolation
10. Identification of Rho GEF and RhoA Activation by Pull-Down Assays
11. Investigating Epidermal Interactions Through an In Vivo Cutaneous Wound-Healing Assay
12. In Vivo Ear Sponge Lymphangiogenesis Assay
13. Abstract 3759: Impact of individual and combined deregulation of miR-143 and miR-506 on cytokinetic and morphometric parameters in A549 lung cancer cells
14. Supplemental Figure 6 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
15. Data from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
16. Supplemental Figure 1 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
17. Supplementary Movie 1 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
18. Supplementary Figures 1-6 from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
19. Supplementary Movie 4 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
20. Supplemental Figure 2 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
21. Supplementary Movie 3 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
22. Data from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
23. Supplemental Figure 4 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
24. Supplementary Methods and Materials, Supplementary Figure Legends from Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
25. Supplemental Figure 5 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
26. Supplemental Figure 3 from Genetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous Carcinoma
27. Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling
28. Genetic deletion or tyrosine phosphatase inhibition of PTPRZ1 activates c‐Met to up‐regulate angiogenesis and lung adenocarcinoma growth.
29. Matrigel Plug Assay for In Vivo Evaluation of Angiogenesis
30. In Vitro Spheroid Sprouting Assay of Angiogenesis
31. In Vitro Wound Healing Assays to Investigate Epidermal Migration
32. Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions
33. Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated Nanoparticles
34. Endothelial RhoA GTPase is essential for in vitro endothelial functions but dispensable for physiological in vivo angiogenesis
35. Chlorotoxin and Lung Cancer: A Targeting Perspective for Drug Delivery
36. Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
37. Multipronged activity of combinatorial miR-143 and miR-506 inhibits Lung Cancer cell cycle progression and angiogenesis in vitro
38. Endothelial‐specific nanodelivery of Rho kinase inhibitors: Targeting tumor angiogenesis and metastasis
39. CDP-diacylglycerol synthetase-controlled phosphoinositide availability limits VEGFA signaling and vascular morphogenesis
40. Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
41. Protein tyrosine phosphatase receptor-ζ1 deletion triggers defective heart morphogenesis in mice and zebrafish
42. MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
43. ORAL CANCER METASTASIS IS INFLUENCED BY GΑ12 SIGNALING: OP189.
44. Delayed Exercise-induced Upregulation of Angiogenic Proteins and Recovery of Motor Function after Photothrombotic Stroke in Mice
45. Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
46. Glycolysis is integral to histamine‐induced endothelial hyperpermeability
47. Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression
48. An iPSC-Derived Neuron Model of CLN3 Disease Facilitates Small Molecule Phenotypic Screening
49. Protein tyrosine phosphatase receptor-ξ1 deletion triggers defective heart morphogenesis in mice and zebrafish.
50. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress–dependent VEGF-C signaling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.